The ACMG Foundation for Genetic and Genomic Medicine's (ACMGF) David L. Rimoin Lifetime Achievement Award in Medical Genetics honors the legacy of Dr. David L. Rimoin, the founding president of the American College of Medical Genetics and Genomics (ACMG).
This distinction annually recognizes an individual whose career exemplifies a lifetime of achievements and the personal qualities embodied by Dr. Rimoin. As the most distinguished of the ACMGF professional awards, only nominees who have made significant contributions to the field of genetics and genomics for more than ten years will be considered. Particularly, this award will honor individuals with Dr. Rimoin's passion for teaching and mentoring, care of patients and their families, and enthusiasm for integrating the medical genetics and genomics community into mainstream healthcare.
As founding president of the ACMG, Dr. Rimoin set the organization on the path to becoming the leader in medical genetics and genomics. As a visionary, admired teacher, prolific author, mentor, beloved friend, researcher and skilled and caring physician for five decades, Dr. Rimoin touched the lives of generations of patients as well as trainees and colleagues.
Read more about Dr. Rimoin's legacy here.
The deadline for the 2021 David L. Rimoin Lifetime Achievement Award in Medical Genetics has passed. If you have any questions about this award please contact ACMG Foundation staff.
The ACMG Foundation for Genetic and Genomic Medicine (ACMGF) established the Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award to honor its first and longstanding Executive Director. Throughout his career, Dr. Watson has worked to advance the knowledge, depth and breadth of genetics and genomics as a primary clinical and laboratory specialty vital to the diagnosis, treatment and prevention of rare and common genetic disorders. To learn more about Dr. Watson’s legacy read, the tribute to Dr. Michael S. Watson and the Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award news release.
The Dr. Michael S. Watson Genetic and Genomic Innovation Award annually recognizes an early career genetic and genomic professional who has demonstrated innovation in his/her work through the development or implementation of a new concept, method or idea that has had significant impact on genetic and genomic medicine. As an innovation award, only nominees who have made contributions to the field of genetics and genomics for less than ten years will be considered.
The distinction includes a monetary gift, a commemorative award, as well as paid travel and registration costs for the ACMG Annual Clinical Genetics meeting or virtual meeting registration. For information about the award criteria please click here.
The deadline for the 2021 Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award has passed. If you have any questions about this award please contact ACMG Foundation staff.